Sobre el estado nutricional de los pacientes con cáncer de pulmón sujetos de tratamiento oncoespecífico
Texto completo:
PDFResumen
Palabras clave
Referencias
Bironzo P, Di Maio M. A review of guidelines for lung cancer. J Thorac Dis 2018;10(Suppl 13):S1556-S1563. Disponible en: http://doi:10.21037/jtd.2018.03.54. Fecha de última visita: 8 de Marzo del 2024.
Visconti R, Morra F, Guggino G, Celetti A. The between now and then of lung cancer chemotherapy and immunotherapy. Int J Mol Sci 2017;18 (7):1374. Disponible en: http://doi:10.3390/ijms18071374. Fecha de última visita: 8 de Marzo del 2024.
Rosell R, Taron M, Massuti B, Mederos N, Magri I, Santarpia M, Sanchez JM. Predicting response to chemotherapy with early-stage lung cancer. Cancer J 2011;17:49-56.
Broët P, Camilleri-Broët S, Zhang S, Alifano M, Bangarusamy D, Battistella M; et al. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: Implications for chemotherapy selection. Cancer Res 2009;69:1055-62.
Degens JH, Dingemans AMC, Willemsen AC, Gietema HA, Hurkmans DP, Aerts JG; et al. The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab. J Cachexia Sarcopenia Muscle 2021;12: 657-64.
Kiss N, Isenring E, Gough K, Krishnasamy M. The prevalence of weight loss during (chemo)radiotherapy treatment for lung cancer and associated patient-and treatment-related factors. Clin Nutr 2014;33:1074-80.
Shepshelovich D, Xu W, Lu L, Fares A, Yang P, Christiani D; et al. Body mass index (BMI), BMI change, and overall survival in patients with SCLC and NSCLC: A pooled analysis of the international lung cancer consortium. J Thorac Oncol 2019;14:1594-607.
Wang X, Jiang R, Li K. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer. Cell Biochem Biophys 2014;69: 633-40.
Neel DR, McClave S, Martindale R. Hypoalbuminaemia in the perioperative period: Clinical significance and management options. Best Pract Res Clin Anaesthesiol 2011;25:395-400. Disponible en: http://doi:10.1016/j.bpa.2011.07.006. Fecha de última visita: 8 de Marzo del 2024.
Nipper CA, Lim K, Riveros C, Hsu E, Ranganathan S, Xu J; et al. The association between serum albumin and post-operative outcomes among patients undergoing common surgical procedures: An analysis of a multi-specialty surgical cohort from the national surgical quality improvement program (NSQIP). J Clin Med 2022;11 (21):6543. Disponible en: http://doi:10.3390/jcm11216543. Fecha de última visita: 8 de Marzo del 2024.
Yang N, Han X, Yu J, Shu W, Qiu F, Han J. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy. J Cancer Res Ther 2020;16:1134-9.
Piskorz L, Lesiak T, Brocki M, Klimek-Piskorz E, Smigielski J, Misiak P, Jablonski S. Biochemical and functional indices of malnutrition in patients with operable, non-microcelullar lung cancer. Nutrición Hospitalaria [España] 2011;26: 1025-32.
Miura K, Hamanaka K, Koizumi T, Kitaguchi Y, Terada Y, Nakamura D; et al. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: comparative study of normal lung, emphysema, and pulmonary fibrosis. Lung Cancer 2017; 111:88-95.
Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature. Nutr J 2010; 9:1-16.
Wildes TJ, DiVita Dean B, Flores CT. Myelopoiesis during solid cancers and strategies for immunotherapy. Cells, 2021;10(5):968. Disponible en: http://doi:10.3390/cells10050968. Fecha de última visita: 8 de Marzo del 2024.
Fernández Vallone VB, Hofer EL, Choi H, Bordenave RH, Batagelj E, Feldman L; et al. Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis. Clin Exp Metastasis 2013;30:317-32.
Alexandrakis MG, Passam FH, Perisinakis K, Ganotakis E, Margantinis G, Kyriakou DS, Bouros D. Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med 2002;96: 553-8.
Huang Y, Wei S, Jiang N, Zhang L, Wang S, Cao X; et al. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: A systematic review and meta-analysis. BMC Cancer 2018;18:1-15.
Chong’an X, Yan G, Lin L, Lili X, Shu L. Impact of anemia on chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer. Chinese J Lung Cancer 2010;13(10):968-74. Disponible en: http://doi:10.3779/j.issn.1009-3419.2010.10.07. Fecha de última visita: 8 de Marzo del 2024.
Shitara K, Matsuo K, Oze I, Mizota A, Kondo C, Nomura M; et al. Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy. Cancer Chemother Pharmacol 2011;68:301-7.
Yuan Y, Zhong H, Ye L, Li Q, Fang S, Gu W, Qian Y. Prognostic value of pretreatment platelet counts in lung cancer: A systematic review and meta-analysis. BMC Pulmonary Med 2020;20: 1-11.
Ganti AK, Loberiza FR, Kessinger A. Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer. Anticancer Res 2010; 30:1365-9.
Zhou JG, Tian X, Cheng L, Zhou Q, Liu Y, Zhang Y; et al. The risk of neutropenia and leukopenia in advanced non-small cell lung cancer patients treated with erlotinib: A prisma-compliant systematic review and meta-analysis. Medicine 2015;94(40):e1719. Disponible en: http://doi:10.1097/MD.0000000000001719. Fecha de última visita: 8 de Marzo del 2024.
Hart L, Ogbonnaya A, Boykin K, Deyoung K, Bailey R, Heritage T; et al. Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices. Cancer Med 2023; 12:10020-30.
Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity 2019;51(1):27-41. Disponible en: http://doi:10.1016/j.immuni.2019.06.025. Fecha de última visita: 8 de Marzo del 2024.
Gao W, Liu Q, Zhou Y, Yang M, Yu Y. The predictive model construction for immune-related adverse events in non-small cell lung cancer patients receiving immunotherapy. Technol Cancer Res Treatment 2023;22: 15330338231206705. Disponible en: http://doi:10.1177/15330338231206705. Fecha de última visita: 8 de Marzo del 2024.
Buonacera A, Stancanelli B, Colaci M, Malatino L. Neutrophil to Lymphocyte Ratio: An emerging marker of the relationships between the immune system and diseases. Int J Mol Sci 2022;23(7): 3636. Disponible en: http://doi:10.3390/ijms23073636. Fecha de última visita: 8 de Marzo del 2024.
Huang Z, Wu L, Hou Z, Zhang P, Li G, Xie J. Eosinophils and other peripheral blood biomarkers in glioma grading: A preliminary study. BMC Neurol 2019; 19:1-11.
Wang L, Long W, Li PF, Lin YB, Liang Y. An elevated peripheral blood Monocyte-to-Lymphocyte ratio predicts poor prognosis in patients with primary pulmonary lymphoepithelioma-like carcinoma. PLoS One 2015;10(5): e0126269. Disponible en: http://doi:10.1371/journal.pone.0126269. Fecha de última visita: 8 de Marzo del 2024.
Zhang H, Gao L, Zhang B, Zhang L, Wang C. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: A systematic review and meta-analysis. Scientific Reports 2016;6(1): 22618. Disponible en: http://doi:10.1038/srep22618. Fecha de última visita: 8 de Marzo del 2024.
Jin J, Yang L, Liu D, Li WM. Prognostic value of pretreatment lymphocyte-to-monocyte ratio in lung cancer: A systematic review and meta-analysis. Technol Cancer Res Treat 2021;20: 1533033820983085. Disponible en: http://doi:10.1177/1533033820983085. Fecha de última visita: 8 de Marzo del 2024.
Ryu JH, Ko HJ, Shim JR, Lee TB, Yang KH, Lee JH; et al. (2020). Eosinophil-to-monocyte ratio is an excellent predictor of acute cellular rejection in pancreas transplant alone recipients. Clin Transplant 2020;34(3):e13785. Disponible en: http://doi:10.1111/ctr.13785. Fecha de última visita: 8 de Marzo del 2024.
Bermúdez Abreut K, Díaz Molina M, Álvarez Arzola R. Sobre el estado nutricional de los pacientes con cáncer de pulmón sujetos de quimioterapia citorreductora. RCAN Rev Cubana Aliment Nutr 2023;33:74-90.
Bermúdez Abreut K, Díaz Molina M, Álvarez Arzola R. Sobre la influencia de la quimioterapia citorreductora en el estado nutricional de los pacientes con cáncer de pulmón. RCAN Rev Cubana Aliment Nutr 2023;33(2):XX-YY.
Weiner JS, Lourie JA. Human biology. A guide to field methods. International Biological Program. Handbook number 9. Blackwell Scientific Publications. Oxford: 1969.
Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Second Edition. Human Kinetics Books. Champaign [Illinois]: 1991. pp 44-47.
Gupta SK. Intention-to-treat concept: A review. Perspect Clin Res 2011;2(3): 109-12. Disponible en: http://doi:10.4103/2229-3485.83221. Fecha de última visita: 27 de Marzo del 2024.
Hosmer Jr DW, Lemeshow S, Sturdivant RX. Applied logistic regression. John Wiley & Sons. New York: 2013.
Pigott TD. A review of methods for missing data. Educ Res Eval 2001;7: 353-83.
Kullo IJ, Hensrud DD, Allison TG. Comparison of numbers of circulating blood monocytes in men grouped by body mass index (< 25, 25 to < 30, ≥ 30). Am J Cardiol 2002;89:1441-43.
Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH; et al. Blood eosinophil count in the general population: Typical values and potential confounders. Eur Respir J 2020;55: 1901874. Disponible en: http://doi:10.1183/13993003.01874-2019. Fecha de última visita: 27 de Marzo del 2024.
Ouyang W, Liu Y, Deng D, Zhou F, Xie C. The change in peripheral blood monocyte count: A predictor to make the management of chemotherapy-induced neutropenia. J Cancer Res Ther 2018; 14(Suppl 3):S565-S570.
Onesti CE, Josse C, Boulet D, Thiry J, Beaumecker B, Bours V, Jerusalem G. Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse. Oncoimmunology 2020;9(1):1761176. Disponible en: http://doi:10.1080/2162402X.2020.1761176. Fecha Fecha de última visita: 27 de Marzo del 2024.
Ikeda S, Yoshioka H, Ikeo S, Morita M, Sone N, Niwa T; et al. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status. BMC Cancer 2017;17:1-8.
Li P, Li J, Lai Y, Wang Y, Wang X, Su J, Che G. Perioperative changes of serum albumin are a predictor of postoperative pulmonary complications in lung cancer patients: A retrospective cohort study. J Thorac Dis 2018;10(10):5755-63. Disponible en: http://doi:10.21037/jtd.2018.09.113. Fecha de última visita: 8 de Marzo del 2024.
Levitt DG, Levitt MD. Human serum albumin homeostasis: A new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016;9: 229-55.
Peng B, Wang Y-H, Liu Y-M, Ma L-X. Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: A systemic review and meta-analysis. Int J Clin Exp Med 2015;8:3098-106.
Huang H, Li L, Luo W, Yang Y, Ni Y, Song T; et al. Lymphocyte percentage as a valuable predictor of prognosis in lung cancer. J Cell Mol Medicine 2022;26: 1918-31.
Yilmaz B, Somay E, Topkan E, Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy. BMC Oral Health 2023;23(1):231. Disponible en: http://doi:10.1186/s12903-023-02937-9. Fecha de última visita: 8 de Marzo del 2024.
Mo CJ, Hu ZJ, Qin SZ, Chen HP, Huang L, Li S, Cao Z. Diagnostic value of platelet‐lymphocyte ratio and hemoglobin‐platelet ratio in patients with rectal cancer. J Clin Lab Analysis 2020; 34(4):e23153. Disponible en: http://doi:10.1002/jcla.23153. Fecha de última visita: 8 de Marzo del 2024.
Hu Z, Tan S, Chen S, Qin S, Chen H, Huang Z; et al. Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer. Clin Chim Acta 2019;501:48-52.
Laurie SA, Jeyabalan N, Nicholas G, MacRae R, Dahrouge S. Association between anemia arising during therapy and outcomes of chemoradiation for limited small-cell lung cancer. J Thorac Oncol 2006;1(2):146-51. Disponible en: http://doi:10.1016/s1556-0864(15)31530-6. Fecha de última visita: 8 de Marzo del 2024.
Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: A systematic review and meta-analysis. Int J Clin Exp Med 2015; 8:5379-87.
Sibille A, Corhay JL, Louis R, Ninane V, Jerusalem G, Duysinx B. Eosinophils and Lung Cancer: From Bench to Bedside. Int J Mol Sci 2022;23(9):5066. Disponible en: http://doi:10.3390/ijms23095066. Fecha de última visita: 8 de Marzo del 2024.
Varricchi G, Galdiero MR, Loffredo S, Lucarini V, Marone G, Mattei F; et al. Eosinophils: The unsung heroes in cancer? Oncoimmunology 2018;7(2): e1393134. Disponible en: http://doi:10.1080/2162402X.2017.1393134. Fecha de última visita: 8 de Marzo del 2024.
Simon SC, Utikal J, Umansky V. Opposing roles of eosinophils in cancer. Cancer Immunol Immunother 2019;68: 823-33. Disponible en: http://doi:10.1007/s00262-018-2255-4. Fecha de última visita: 8 de Marzo del 2024.
Beishuizen A, Vermes I. Relative eosinophilia (Thorn test) as a bioassay to judge the clinical relevance of cortisol values during severe stress. J Clin Endocrinol Metab 1999;84:3400-1.
Pelekanou V, Kampa M, Kiagiadaki F, Deli A, Theodoropoulos P, Agrogiannis G; et al. Estrogen anti-inflamatory activity on human monocytes is mediated through cross-talk between estrogen receptor ER36 and GPR30/GPER1. J Leukoc Biol 2016; 99:333-47.
Ownby HE, Roi LD, Isenberg RR, Brennan MJ. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer 1983;52:126-30.
Holub K., Biete A. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients. Clin Transl Oncol 2019;21:836-44. Disponible en: http://doi:10.1007/s12094-018-1991-4. Fecha de última visita: 8 de Marzo del 2024.
Enlaces refback
- No hay ningún enlace refback.
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.